A Prospective, Open -Label Active -Controlled study to Evaluate the Pharmacokinetics Pharmacodynamics, Saftey and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age after the Fontan procedure

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2016 - July 6, 2021